Literature DB >> 4770124

Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside.

W Cendrowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4770124

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN： 0300-9009            Impact factor:   2.396


× No keyword cloud information.
  5 in total

Review 1.  Cyclophosphamide for multiple sclerosis.

Authors:  L La Mantia; C Milanese; N Mascoli; R D'Amico; B Weinstock-Guttman
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  Short-term intensive cyclophosphamide treatment in multiple sclerosis. A retrospective controlled study.

Authors:  P Theys; F Gosseye-Lissoir; P Ketelaer; H Carton
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

3.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

4.  Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.

Authors:  R E Gonsette; L Demonty; P Delmotte
Journal:  J Neurol       Date:  1977-02-17       Impact factor: 4.849

5.  Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.

Authors:  Francesco Patti; Salvatore Lo Fermo
Journal:  Autoimmune Dis       Date:  2011-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.